Longevity: the role of medical innovation
Over the last two centuries, progress in medicine and hygiene has been the main driver behind the considerable gains in life expectancy. Daniel Vasella, Chairman of the Novartis pharmaceuticals group, talks about potential short- and medium-term progress in pharmaceutical innovation and the performance of prevention and treatment.
Dr. Daniel Vasella
Chairman of Novartis
All the video clips
Pr. L. Stephen Coles
Doctor of Medecine and Mathematics, Director of the Gerontology Research Group, Director of the Supercentenarian Research Foundation, Professor of Chemistry and Biochemistry at the University of California Los Angeles (USA)
Pr. Françoise Forette
Geriatrician, President of the International Longevity Centre (ILC) France, Co-president of the Alliance pour la Santé et l’Avenir (France)
Pr. Carol Jagger
Professor of epidemiology of aging, Institute for Ageing and Health (IAH), University of Newcastle (UK)
Pr. Thomas Kirkwood
Professor of medicine and biologist, Director of the Institute for Ageing and Health (IAH), University of Newcastle (UK)
Pr. Jean-Marie Robine
Demographer and epidemiologist, Head of Research at INSERM (National Health and Medical Research Institute), Paris and Montpellier (France)
Pr. James W. Vaupel
Demographer, Founder and director of the Max Planck Institute for Demographic Research, Rostock (Germany)






